A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/41 (2006.01) A61P 9/06 (2006.01)
Patent
CA 2525665
The invention relates to pharmaceutical compositions and a method of preventing or reducing the incidence of AF and thereby reducing the risk of morbidity and mortality in patients having symptomatic heart failure comprising administering to such patient an effective amount of valsartan, or pharmaceutically acceptable salts thereof, alone or in combination with another therapeutic agent, optionally in the presence of a pharmaceutically acceptable carrier.
La présente invention a trait à des compositions pharmaceutiques et un procédé de prévention ou de réduction de l'incidence de la fibrillation auriculaire réduisant ainsi le risque de maladie et de mortalité chez des patients souffrant d'insuffisance cardiaque symptomatique comprenant l'administration à un tel patient d'une quantité efficace de valsartan, ou les sels pharmaceutiquement acceptables de celui-ci, seul ou en combinaison avec un autre agent thérapeutique, éventuellement en présence d'un support pharmaceutiquement acceptable.
Cohn Jay Norman
Glazer Robert Dean
Latini Robert
Maggioni Aldo Pietro
Tognoni Gianni
Fetherstonhaugh & Co.
Novartis Ag
LandOfFree
Pharmaceutical composition comprising valsartan does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical composition comprising valsartan, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition comprising valsartan will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2063490